# 1. Target: GSR
7 regulons containing the target(s), GSR are overactive in this patient.
None
21 regulons containing the target(s), VEGFA are overactive in this patient.
HALLMARK_HYPOXIA HALLMARK_MTORC1_SIGNALING HALLMARK_TNFA_SIGNALING_VIA_NFKB
# 1. Target: WEE1
11 regulons containing the target(s), WEE1 are overactive in this patient.
None
# 1. Target: APP
41 regulons containing the target(s), APP are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), SV2A are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), KEAP1 are overactive in this patient.
None
No additional evidence was found
2 regulons containing the target(s), HBB are overactive in this patient.
None
No additional evidence was found
7 regulons containing the target(s), GSR are overactive in this patient.
None
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ABL1 are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), BSG are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), NDUFA13 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), TSG101 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), NOTCH1 are overactive in this patient.
HALLMARK_NOTCH_SIGNALING HALLMARK_WNT_BETA_CATENIN_SIGNALING
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
17 regulons containing the target(s), ABAT are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), PLA2G2A are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), TRPV4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
50 regulons containing the target(s), UGCG are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
14 regulons containing the target(s), CA2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
24 regulons containing the target(s), ANGPT2 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
32 regulons containing the target(s), ANGPT2,VEGFA are overactive in this patient.
HALLMARK_HYPOXIA HALLMARK_MTORC1_SIGNALING HALLMARK_TNFA_SIGNALING_VIA_NFKB
No glioblastoma clinical trials were found for these drugs.
21 regulons containing the target(s), VEGFA are overactive in this patient.
HALLMARK_HYPOXIA HALLMARK_MTORC1_SIGNALING HALLMARK_TNFA_SIGNALING_VIA_NFKB
No glioblastoma clinical trials were found for these drugs.
10 regulons containing the target(s), EEF2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
9 regulons containing the target(s), TNC are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
18 regulons containing the target(s), MAPK1,MAPK3 are overactive in this patient.
None
No additional evidence was found
42 regulons containing the target(s), HRH1 are overactive in this patient.
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_KRAS_SIGNALING_UP
No additional evidence was found
7 regulons containing the target(s), PLA2G2A,PLA2G5 are overactive in this patient.
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_TNFA_SIGNALING_VIA_NFKB
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
13 regulons containing the target(s), SLC6A9 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
24 regulons containing the target(s), ANGPT1,ANGPT2 are overactive in this patient.
No additional evidence was found
42 regulons containing the target(s), HRH1,SLC6A2 are overactive in this patient.
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_KRAS_SIGNALING_UP
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), SOD1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ACVR2B are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
14 regulons containing the target(s), CA2,CA4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
9 regulons containing the target(s), OXTR are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
21 regulons containing the target(s), PGF,VEGFA are overactive in this patient.
HALLMARK_HYPOXIA HALLMARK_MTORC1_SIGNALING HALLMARK_TNFA_SIGNALING_VIA_NFKB
45 regulons containing the target(s), SERPINE1 are overactive in this patient.
HALLMARK_TNFA_SIGNALING_VIA_NFKB HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_TGF_BETA_SIGNALING HALLMARK_UV_RESPONSE_DN HALLMARK_APOPTOSIS HALLMARK_COMPLEMENT
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
***Warning message: Missing column names filled in: ‘X15’ [15], ‘X16’ [16], ‘X17’ [17], ‘X18’ [18], ‘X19’ [19], ‘X20’ [20], ‘X21’ [21], ‘X22’ [22], ‘X23’ [23], ‘X24’ [24], ‘X25’ [25], ‘X26’ [26], ‘X27’ [27], ‘X28’ [28], ‘X29’ [29], ‘X30’ [30], ‘X31’ [31], ‘X32’ [32], ‘X33’ [33], ‘X34’ [34], ‘X35’ [35], ‘X36’ [36], ‘X37’ [37], ‘X38’ [38], ‘X39’ [39], ‘X40’ [40], ‘X41’ [41], ‘X42’ [42], ‘X43’ [43], ‘X44’ [44], ‘X45’ [45], ‘X46’ [46], ‘X47’ [47], ‘X48’ [48], ‘X49’ [49], ‘X50’ [50], ‘X51’ [51], ‘X52’ [52], ‘X53’ [53], ‘X54’ [54], ‘X55’ [55], ‘X56’ [56], ‘X57’ [57], ‘X58’ [58], ‘X59’ [59], ‘X60’ [60], ‘X61’ [61], ‘X62’ [62], ‘X63’ [63], ‘X64’ [64], ‘X65’ [65], ‘X66’ [66], ‘X67’ [67], ‘X68’ [68], ‘X69’ [69], ‘X70’ [70], ‘X71’ [71], ‘X72’ [72], ‘X73’ [73], ‘X74’ [74], ‘X75’ [75], ‘X76’ [76], ‘X77’ [77], ‘X78’ [78], ‘X79’ [79], ‘X80’ [80], ‘X81’ [81], ‘X82’ [82], ‘X83’ [83], ‘X84’ [84], ‘X85’ [85], ‘X86’ [86], ‘X87’ [87], ‘X88’ [88], ‘X89’ [89], ‘X90’ [90], ‘X91’ [91], ‘X92’ [92], ‘X93’ [93], ‘X94’ [94], ‘X95’ [9 [… truncated]